ArticleAging clinical and experimental research2025
Frailty modulates the predictive value of performance status in older adults living with cancer.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of Adjuvant Chemotherapy on the Prognosis in Elderly Patients with Stage II and III Colorectal Cancer: A Retrospective Multicenter Study.Cancer management and research · 2026Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
backgroundCancer prognosis in older adults is complicated by age-related vulnerabilities such as frailty, which may impact the performance of traditional prognostic tools, which may not accurately reflect risk in this population.
aimsThis study aimed to assess whether frailty modifies the association between a modified performance status (PS) -constructed from days spent in bed, physical activity, and disability-and mortality risk in older adults with cancer.
methodsWe conducted a secondary analysis of the Mexican Health and Aging Study (MHAS), including individuals ≥50 years with incident cancer and active treatment, with follow-up through 2021. A frailty index (FI) was calculated using a 33-item deficit accumulation model. Modified PS was constructed using data on days in bed, functional limitations, and physical activity. Participants were stratified into low (<0.25) and high (≥0.25) frailty levels. Cox regression and Kaplan-Meier curves were used to assess associations with all-cause mortality.
resultsAmong 318 participants (mean age 68.0 years; 62.6% women), frailty and performance status were both associated with mortality. In individuals with low frailty, modified PS categories 2 and 4 were significantly associated with higher mortality (HR 5.46 [95% CI: 1.24-24.04], and HR 8.01 [1.50-42.66], respectively). Among those with high frailty, only age remained a significant predictor of mortality (HR 1.04 [1.00-1.07]). DISCUSSION: Frailty significantly modifies the prognostic value of performance status. In frail older adults with cancer, the predictive utility of performance status tools is reduced.
conclusionsIncorporating frailty assessment may enhance risk stratification and clinical decision-making in older adults with cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.